Literature DB >> 1834816

Obesity in the dog: role of the adrenal steroid dehydroepiandrosterone (DHEA).

E G MacEwen1, I D Kurzman.   

Abstract

It is estimated that 25-50% of pet dogs are overweight. In rodents and humans the adrenal steroid dehydroepiandrosterone (DHEA) has been associated with loss of body weight and reduction in total body fat content. We have shown that administration of DHEA results in weight loss in spontaneously obese dogs. DHEA also lowered serum cholesterol, in particular, the low density lipoprotein component of the plasma cholesterol. We hypothesize that treatment of obese dogs with DHEA in combination with a low energy, high fiber diet will result in greater weight loss when compared with dogs on the same diet, without DHEA. In the current study, spontaneously obese dogs were fed a uniform low energy, high fiber diet and then randomized to receive DHEA or placebo. Preliminary results show that the mean total body weight lost for dogs receiving DHEA was 3.59 kg compared with 2.38 kg for dogs receiving placebo (P greater than 0.05). The percent excess body weight (above ideal body weight) lost for the DHEA group was 65.7 versus 31.4 for the placebo group (P less than 0.02). The percent excess body weight lost per month on the study for the DHEA group was 15 versus 8.2 for the placebo group (P = 0.069). Although these results are preliminary, they indicate that DHEA combined with a low energy, high fiber diet enhances the loss of excess body weight compared with diet modification alone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1834816     DOI: 10.1093/jn/121.suppl_11.S51

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  4 in total

1.  Prostate cancer risk: the significance of differences in age related changes in serum conjugated and unconjugated steroid hormone concentrations between Arab and Caucasian men.

Authors:  E O Kehinde; A O Akanji; A Memon; A A Bashir; A S Daar; K A Al-Awadi; T Fatinikun
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

Review 2.  Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.

Authors:  Sylvie Legrain; Laurence Girard
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 3.  Might DHEA be considered a beneficial replacement therapy in the elderly?

Authors:  Alessandro D Genazzani; Chiara Lanzoni; Andrea R Genazzani
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

4.  Impact of Dehydroepiandrosterone Sulfate on Newborn Leukocyte Telomere Length.

Authors:  Han Liu; Guangdi Zhou; Qian Chen; Fengxiu Ouyang; Julian Little; Jun Zhang; Dan Chen
Journal:  Sci Rep       Date:  2017-02-10       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.